TY - JOUR
T1 - Biliary excretion and enterohepatic cycling of zearalenone in immature pigs
AU - Biehl, Michael L.
AU - Prelusky, Daniel B.
AU - Koritz, Gary D.
AU - Hartin, Kenneth E.
AU - Buck, William B.
AU - Trenholm, H. Locksley
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 1993
Y1 - 1993
N2 - The disposition of the estrogenic mycotoxin, zearalenone (ZEN) in female, 10- to 14-week-old Yorkshire pigs was investigated. Pigs were administered [3H]ZEN intravenously (IV; n = 4; 5 mg/kg; 15 μCi/kg), orally (n = 4; 10 mg/kg; 30 μCi/kg), or intravenously with bile removal (IVB; n = 2; 5 mg/kg; 15 μCi/kg). Plasma, urine, feces, and bile (IVB pigs only) were serially collected and analyzed for radioactivity. Metabolite profiles were determined in plasma and bile by HPLC. The biological half-life of total plasma radioactivity in IV and orally dosed pigs (86.6 hr) was much larger than that of IVB animals (3.34 hr). Metabolite profiles of plasma concentration vs time demonstrated secondary peaks in concentration during the terminal elimination phase in IV and orally dosed pigs. In IVB pigs these peaks were absent, relative metabolite profiles were altered, and ZEN and metabolites were no longer detectable after 16 hr postdosing. Biliary recovery of radioactivity, principally as glucuronide conjugates, was extensive (45.61 ± 4.73%) in IVB pigs and significantly greater (p < 0.05) than that of fecal recovery of radioactivity in IV (6.56 ± 0.78) or orally dosed (21.74 ± 1.56%) pigs. Intraduodenal administration of bile containing [3H]ZEN and metabolites resulted in recovery of 64.56 ± 4.89% of the dose in bile, 20.78 ± 3.94% in urine, and the presence of glucuronide conjugates of ZEN and α-zearalenol (ZEL) in portal and jugular plasma. Differences in metabolite profiles between administered bile and sampled plasma suggest that the intestinal mucosa was active in reducing ZEN to ZEL and conjugating these metabolites with glucuronic acid. These studies provide evidence for extensive biliary secretion and enterohepatic cycling of ZEN and metabolites in pigs.
AB - The disposition of the estrogenic mycotoxin, zearalenone (ZEN) in female, 10- to 14-week-old Yorkshire pigs was investigated. Pigs were administered [3H]ZEN intravenously (IV; n = 4; 5 mg/kg; 15 μCi/kg), orally (n = 4; 10 mg/kg; 30 μCi/kg), or intravenously with bile removal (IVB; n = 2; 5 mg/kg; 15 μCi/kg). Plasma, urine, feces, and bile (IVB pigs only) were serially collected and analyzed for radioactivity. Metabolite profiles were determined in plasma and bile by HPLC. The biological half-life of total plasma radioactivity in IV and orally dosed pigs (86.6 hr) was much larger than that of IVB animals (3.34 hr). Metabolite profiles of plasma concentration vs time demonstrated secondary peaks in concentration during the terminal elimination phase in IV and orally dosed pigs. In IVB pigs these peaks were absent, relative metabolite profiles were altered, and ZEN and metabolites were no longer detectable after 16 hr postdosing. Biliary recovery of radioactivity, principally as glucuronide conjugates, was extensive (45.61 ± 4.73%) in IVB pigs and significantly greater (p < 0.05) than that of fecal recovery of radioactivity in IV (6.56 ± 0.78) or orally dosed (21.74 ± 1.56%) pigs. Intraduodenal administration of bile containing [3H]ZEN and metabolites resulted in recovery of 64.56 ± 4.89% of the dose in bile, 20.78 ± 3.94% in urine, and the presence of glucuronide conjugates of ZEN and α-zearalenol (ZEL) in portal and jugular plasma. Differences in metabolite profiles between administered bile and sampled plasma suggest that the intestinal mucosa was active in reducing ZEN to ZEL and conjugating these metabolites with glucuronic acid. These studies provide evidence for extensive biliary secretion and enterohepatic cycling of ZEN and metabolites in pigs.
UR - http://www.scopus.com/inward/record.url?scp=0027282356&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027282356&partnerID=8YFLogxK
U2 - 10.1006/taap.1993.1140
DO - 10.1006/taap.1993.1140
M3 - Article
C2 - 8337696
AN - SCOPUS:0027282356
SN - 0041-008X
VL - 121
SP - 152
EP - 159
JO - Toxicology and Applied Pharmacology
JF - Toxicology and Applied Pharmacology
IS - 1
ER -